NCT01509742已完成1 期
Effect of NNC 90-1170 on Hypoglycaemic Counterregulation During Stepwise Hypoglycaemic Clamp in Type 2 Diabetic Subjects. A Double-blind, Placebo-controlled, Randomised, 2-period Cross-over Trial
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 19
- 试验地点
- 1
- 主要终点
- Area under the Curve (AUC) glucagon
研究概览
简要总结
This trial is conducted in Europe. The aim of this trial is to examine the effect of NNC 90-1170 on the hypoglycaemic counterregulation in subjects with type 2 diabetes.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 30 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
NNC 90-1170
Experimental
干预措施: liraglutide (Drug)
Placebo
Placebo Comparator
干预措施: placebo (Drug)
结局指标
主要结局
Area under the Curve (AUC) glucagon
次要结局
- Glucose
- Adrenaline
- Insulin secretion
- Noradrenaline
- Cortisol
- Growth hormone
- Adverse events
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With Type 2 DiabetesDiabetesDiabetes Mellitus, Type 2NCT01508923Novo Nordisk A/S17
已完成
1 期
Effect of Liraglutide on Pulsatile Insulin Secretion in Subjects With Type 2 DiabetesDiabetesDiabetes Mellitus, Type 2NCT01507311Novo Nordisk A/S11
已完成
2 期
Effect of Liraglutide on Weight and Appetite in Obese Subjects With Type 2 DiabetesDiabetesDiabetes Mellitus, Type 2NCT01508949Novo Nordisk A/S35
已完成
1 期
Comparison of Hypoglycaemic Response Between NN1250 and Insulin Glargine in Type 1 DiabeticsDiabetesDiabetes Mellitus, Type 1NCT01002768Novo Nordisk A/S28
已完成
1 期
A Trial Investigating the Effect of NN5401 in Subjects With Type 2 DiabetesDiabetesDiabetes Mellitus, Type 2NCT01134224Novo Nordisk A/S39